I called multiple times to transfer a prescription from my old pharmacy to express scripts and each time they told me the hold time was too long so they had to hang up on the old pharmacy and they ...

Express Scripts is suing the Federal Trade Commission (FTC), demanding the retraction of a report it claims is false and harmful to the pharmacy benefit manager (PBM) industry. Express Scripts is ...

Express Scripts, Inc. sued the Federal Trade Commission on Tuesday over a report the pharmacy benefit management company called "unfair, biased, erroneous and defamatory." Headquartered in North ...

Express Scripts, one of the country’s largest pharmacy benefit managers, sued the Federal Trade Commission (FTC) Tuesday and demanded the agency retract a report saying the industry middlemen ...

Cigna subsidiary Express Scripts Inc. claimed the Federal Trade Commission’s July interim report—which claims middlemen have driven up prescription drug costs and exacerbated independent ...

Express Scripts, one of the largest pharmacy benefit managers in the U.S., filed a lawsuit on Tuesday demanding that a recent Federal Trade Commission report accusing industry middlemen of raising ...

Refers to the latest 2 years of stltoday.com stories. Cancel anytime. The Express Scripts building on the company’s north campus is photographed on Thursday, March 8, 2018, in Berkeley ...

ST. LOUIS (CN) — Express Scripts filed a federal lawsuit against the Federal Trade Commission on Tuesday, claiming its report blaming the pharmacy benefit management industry for rising drug costs was ...

Express Scripts, one of the biggest PBMs in the U.S., launched a lawsuit Tuesday against the Federal Trade Commission (FTC) over the agency’s recent report that examined PBM practices in driving up ...

On Tuesday, the healthcare company’s PBM, Express Scripts, sued the Federal Trade Commission over the agency’s recent report showing how the drug middlemen could be contributing to rising drug ...

NEW YORK (Reuters) -Pharmacy benefit manager Express Scripts sued the U.S. Federal Trade Commission on Tuesday over the regulator's recent drug pricing report, calling the report's conclusion that the ...